Teva's CGRP Migraine Med Hits a Stumbling Block Post author:Sam Post published:February 8, 2018 Post category:BioPharma It’s starting to feel like Teva can’t catch a break. Source: BioSpace You Might Also Like Agile Therapeutics, Inc. Reports Fourth Quarter And Full Year 2016 Financial Results March 8, 2017 Perrigo Cuts 750 Jobs, Sells MS Drug Royalties for $2.85 Billion and Loses CFO to Amgen February 27, 2017 Bone Biologics Announces Appointment Of To Company???s Board Of Directors August 3, 2017
Perrigo Cuts 750 Jobs, Sells MS Drug Royalties for $2.85 Billion and Loses CFO to Amgen February 27, 2017
